AGM/EGMApr 29, 2026, 04:31 PM
GLUE 2026 Annual Meeting on June 11; Director Elections, Auditor Ratification
AI Summary
Monte Rosa Therapeutics, Inc. (GLUE) announced its 2026 Annual Meeting of Stockholders will be held virtually on June 11, 2026, at 8:30 a.m. Eastern Time. Stockholders will vote on the election of three Class II director nominees and the ratification of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026. The board of directors recommends a vote "FOR" both proposals.
Key Highlights
- 2026 Annual Meeting of Stockholders to be held virtually on June 11, 2026, at 8:30 a.m. ET.
- Stockholders of record as of April 16, 2026, are entitled to vote at the Annual Meeting.
- Proposals include the election of three Class II director nominees to serve until 2029.
- Ratification of Deloitte & Touche LLP as independent auditor for fiscal year ending December 31, 2026.
- 84,382,573 shares of common stock were outstanding as of the April 16, 2026 record date.
- Proxy materials were made available to stockholders on or about April 29, 2026.
Price Impact
More from GLUE